Eltink, Charlotte <br/><br/>
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β₃-adrenoceptor agonist for treatment of overactive bladder.  [electronic resource] 

 -  International journal of clinical pharmacology and therapeutics  Nov 2012 
 - 838-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0946-1965 
<br/><br/><label>Standard No.: </label>10.5414/CP201782  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetanilides--administration & dosage<br/>Administration, Oral<br/>Adolescent<br/>Adrenergic beta-3 Receptor Agonists--administration & dosage<br/>Adult<br/>Area Under Curve<br/>Biological Availability<br/>Biotransformation<br/>Body Weight<br/>Cross-Over Studies<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Linear Models<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Models, Biological<br/>Netherlands<br/>Sex Factors<br/>Thiazoles--administration & dosage<br/>Urinary Bladder, Overactive--drug therapy<br/>Washington<br/>Young Adult